000520 — Samil Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩211bn
- KR₩368bn
- KR₩220bn
Annual cashflow statement for Samil Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,341 | -5,347 | -28.3 | 1,664 | -5,629 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9,782 | 9,678 | 8,806 | 7,734 | 12,975 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7,547 | -7,626 | -9,613 | -2,599 | -11,598 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7,775 | 1,417 | 4,154 | 11,746 | 2,590 |
| Capital Expenditures | -17,211 | -33,091 | -48,656 | -24,391 | -5,612 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 12,622 | -12,217 | 12,720 | 4,613 | -749 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,589 | -45,308 | -35,936 | -19,778 | -6,361 |
| Financing Cash Flow Items | -1,969 | -1,893 | -1,877 | -7,603 | -7,494 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3,323 | 31,874 | 29,706 | 8,483 | 7,982 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -721 | -12,005 | -2,089 | -997 | 4,231 |